Cav-1 negative tumors show increased tumor progression, metastasis, and estrogen receptor-negative genotype compared to Cav-1 positive breast cancer (Sloan et al., 2009; Witkiewicz et al., 2009; Qian et al., 2011; Simpkins et al., 2012). Here, CAV1 is linked to neoplasm.